Shares of Thermo Fisher Scientific Inc. TMO, -0.73% were little changed in premarket trading Tuesday, after the analytics, diagnostics and laboratory services company announced a new $4 billion stock
Thermo Fisher is seeing the collapse of its COVID-19 diagnostic business. It's also suffering from its customers tightening their purse strings.
Thermo Fisher and Abbott are two of our key Healthcare holdings in our fund, and both are among our top 10 holdings overall. Abbott and Thermo Fisher focus on different industries which are Healthcare
Ally Financial is a digital bank that offers a dividend yield above 5% at recent prices. Thermo Fisher Scientific's COVID-19 testing revenue has evaporated, but that won't stop the company from raisin
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q3 2023 Earnings Call Transcript October 25, 2023 8:30 AM ET Company Participants Rafael Tejada - VP of IR Marc Casper - Chairman, President and CEO Stephen W
The Dow is the sole major index in the green this morning, boosted by Microsoft's strong performance yesterday afternoon.
Shares of Thermo Fisher Scientific (TMO) slumped over 7% in early trading Wednesday after the maker of lab equipment and analytical instruments posted weaker-than-expected sales and cut its outlook fo
Thermo Fisher Scientific Inc.'s stock TMO, -7.80% fell about 9% Wednesday to put it on track for its lowest close in more than three years, after the supplier of analytics, diagnostics and laboratory
Thermo Fisher Scientific (NYSE:TMO) issued a forecast for full-year profit and sales that falls below Wall Street expectations on lower-than-expected demand for its services used in the production of
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.69 per share, beating the Zacks Consensus Estimate of $5.58 per share. This compares to earnings of $5.08 per share a year ago.
The leading maker of scientific equipment slashes its guidance for the second consecutive quarter, citing a challenging macro environment.
Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expected demand for its services used to make therapeut
Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced that it has agreed to be acquired by Thermo Fisher

Why Olink Stock Is Skyrocketing Today

11:29am, Tuesday, 17'th Oct 2023
Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences solutions.
Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE